An alternative title:
𝐖𝐡𝐨 𝐄𝐯𝐞𝐫 𝐒𝐚𝐢𝐝 𝐖𝐞 𝐀𝐫𝐞 𝐖𝐫𝐨𝐧𝐠? 𝐀 𝐅𝐮𝐭𝐮𝐫𝐞 𝐓𝐫𝐢𝐚𝐥 𝐖𝐢𝐥𝐥 𝐏𝐫𝐨𝐯𝐞 α-𝐒𝐲𝐧𝐮𝐜𝐥𝐞𝐢𝐧 𝐢𝐬 𝐄𝐯𝐢𝐥
*If a trial does not yield the hypothesized results, an "optimized" trial might!
@movedisorder
https://t.co/roLU58cQXS
The case for changing the approach in #Parkinson disease research from lessening the proteinopathy (accrual of amyloids) to correcting the proteinopenia (depletion of normal proteins) --with @MichaelOkun, via @JAMANeuro.
https://t.co/FMBciFzypV
Recording from the #thalamus (Vim) in a patient with #SCS (spinal cord stimulation) and #dbs (deep brain stimulation).
More and more I think this is the way for us to understand how #neuromodulation and the #brain actually work.
With @RobertC21093233, @mhodaie and many more.
Can't believe @AlbertoEspay, @franci_morgante and I reached the 10th ed of our course on #mds
Naples never disappoints: great views, food, friends, incl Nicola Modugno, Alessandro Tessitore, Davide Martino and @Neuronologist1
Where next year?? stay tuned!
https://t.co/HxDEP0046J
I am so lucky I have the chance to learn from the revolutionary way of seeing Movement Disorders shared by @franci_morgante, @AlbertoEspay and @DrAlfonsoFasano! #MDSCourse2022
@SandyCartella@LimpeParkinson@Tom85_58 Here is the entire group! Happy to know that movement disorders still fascinate so many Italian young neurologists!
The neural circuitry reviewed for #tremor in another masterclass by @franci_morgante at the @Limpe_Parkinson Congress in Napoli. She will be among the leaders in the brave emerging treatments based on novel central (DRTT) and peripheral closed-loop stimulation.
Her Majesty Queen Elizabeth II leaves a challenging inheritance to King Charles III: the deep love British people had, still have, for her. She was history, and today the whole world has come together to mourn her passing and celebrate her life. #QueenElizabeth